Arana A, Cuchi T, Arellano F. Strengthening EU pharmacovigilance. European pharmaceutical contractor. European pharmaceutical contracto: EPC. 2009;44-5.
Hauber B, Candrilli S, Snyder EH, McBurney CR. Validation of a model to assess long-term disease progression in Alzheimer's disease patients treated with rivastigmine. Neurobiol Aging. 2004 Jan 1;25:S136.